1J Nemunaitis. GVAX (GM-CSF gene modified tumor vaccine)in advanced stage non -small cell lung cancer[J]. J Control Release, 2003,91(1-2):225-231.
2Nemunaitis J, Sterman D, Jablons D, et al. Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small cell lung cancer[J]. J National Cancer Institute, 2004,94(4):326-331.
3Raez LE, Cassi leth PA, Schlesselman JJ, et al. Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small cell lung cancer[J]. J Clin Oncol, 2004,22(14):2800-2807.
4M Palmer, J Parker, S Modi, et al. Phase I study of the BLP25(MUC-1 peptide) "liposomal vaccine for active specific immmunotherapy in stage ⅢB/IV non-small cell lung cancer[J]. Clin Lung Cancer, 2001,30:49-57.
5Squiban P, Velu T, Menecier B, et al. MVA-MUC1-IL2 vaccine immunotherapy for advanced non-small cell lung cancer (NSCLC): Interim phase Ⅱ data[J]. J Clin Oncol, 2004,22(14S):2544.
6Krug LM, Ragupathi G, Ng KK, et al. Vaccination of small cell lung cancer patients with polysialic acid or N-Propionylated polysialic acid conjugated to Keyhole Limpet Hemoeyanin[J]. Clin Cancer Res, 2004,10:916-923.
7Krug LM, Ragupathi G, Hood C, et al. Vaccination of patients with small-cell lung cancer with Synthetic Fucosy1 GM-1 conjugated to Keyhole Limpet Hemocyanin[J]. Clinical Cancer Res, 2004,10:6094-6100.
8Giaccone G, Debruyne C, Felip F, et al. Phase Ⅲ study of BEC2/BCG vaccinatio in limited disease small cell lung cancer(LD-SCLC) patients, following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study)[J]. J Clin Oncol, 2004,22(14S):7020.
9Ueda Y, Itoh T, Nukaya I, et al. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas[J]. Int J Oncol, 2004,24(4):909-917.
10Nakajima H, Kawasaki K, Oka Y, et al. WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone[J]. Cancer Immunol Imunother, 2004,53(7):617-624.
